Acupressure bands are effective in reducing radiation therapy-related nausea.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 2764274)

Published in J Pain Symptom Manage on March 28, 2009

Authors

Joseph A Roscoe1, Peter Bushunow, Pascal Jean-Pierre, Charles E Heckler, Jason Q Purnell, Luke J Peppone, Yuhchyau Chen, Marilyn N Ling, Gary R Morrow

Author Affiliations

1: University of Rochester James P Wilmot Cancer Center, Rochester, NY 14642, USA. joseph_roscoe@urmc.rochester.edu

Articles cited by this

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol (1993) 18.75

Acupuncture: theory, efficacy, and practice. Ann Intern Med (2002) 4.03

Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos. J Clin Invest (1950) 3.81

Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer (2004) 3.04

Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer. Support Care Cancer (2004) 2.41

Reliability and validity of the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument. Qual Life Res (1999) 2.24

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--an update. Support Care Cancer (2004) 1.56

5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol (2005) 1.43

Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage (2005) 1.37

Can acupuncture have specific effects on health? A systematic review of acupuncture antiemesis trials. J R Soc Med (1996) 1.36

Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer (2004) 1.34

Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol (2005) 1.32

Patient expectations as predictor of chemotherapy-induced nausea. Ann Behav Med (2000) 1.31

Acupuncture: an evidence-based review of the clinical literature. Annu Rev Med (2000) 1.30

Expectation and occurrence of postchemotherapy side effects: nausea and vomiting. Cancer Pract (1995) 1.20

Chemotherapy-related nausea and vomiting - past reflections, present practice and future management. Eur J Cancer Care (Engl) (2004) 1.19

Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychol Bull (1988) 1.19

Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample. Cancer (1997) 1.17

The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage (2003) 1.13

Expectations of chemotherapy-related nausea: emotional and experiential predictors. Ann Behav Med (2003) 1.05

Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment. J Consult Clin Psychol (1987) 1.04

Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study. J Pain Symptom Manage (2008) 0.98

Relationships between patients' pre-treatment expectations of toxicities and post chemotherapy experiences. Psychooncology (2005) 0.98

Seasickness as a self-fulfilling prophecy: raising self-efficacy to boost performance at sea. J Appl Psychol (1995) 0.94

Nonpharmacologic factors in the development of posttreatment nausea with adjuvant chemotherapy for breast cancer. Cancer (1988) 0.94

The continuing problem of post chemotherapy nausea and vomiting: contributions of classical conditioning. Auton Neurosci (2006) 0.87

Effect and placebo effect of acupressure (P6) on nausea and vomiting after outpatient gynaecological surgery. Acta Anaesthesiol Scand (1999) 0.85

Nonpharmacologic treatment of postoperative nausea. J Perianesth Nurs (1996) 0.83

Exploratory analysis of the usefulness of acupressure bands when severe chemotherapy-related nausea is expected. J Soc Integr Oncol (2006) 0.81

Acupressure and acustimulation bands for control of nausea: a brief review. Am J Obstet Gynecol (2002) 0.77

Chinese traditional medicine: an introductory overview. Altern Ther Health Med (1995) 0.76

Articles by these authors

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Lancet (2009) 5.82

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol (2006) 4.97

Cancer-related fatigue: the scale of the problem. Oncologist (2007) 3.03

Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy. J Clin Oncol (2012) 3.03

Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.39

Mechanisms of cancer-related fatigue. Oncologist (2007) 2.25

Community-based clinical oncology research trials for cancer-related fatigue. J Support Oncol (2006) 2.01

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program Study of 360 cancer patients treated in the community. Cancer (2003) 1.98

Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98

Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol (2011) 1.79

Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer (2005) 1.76

Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol (2009) 1.73

Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst (2009) 1.56

Patients' experiences with navigation for cancer care. Patient Educ Couns (2009) 1.55

Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer (2001) 1.52

Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol (2011) 1.51

Cancer-related fatigue and sleep disorders. Oncologist (2007) 1.47

Multicenter, randomized controlled trial of yoga for sleep quality among cancer survivors. J Clin Oncol (2013) 1.46

5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial. Lancet Oncol (2005) 1.43

Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol (2008) 1.40

Traumatic stress symptoms among women with recently diagnosed primary breast cancer. J Trauma Stress (2002) 1.40

Acustimulation wristbands for the relief of chemotherapy-induced nausea. Altern Ther Health Med (2002) 1.39

Occurrence, severity, and longitudinal course of twelve common symptoms in 1129 consecutive patients during radiotherapy for cancer. J Pain Symptom Manage (2005) 1.37

Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist (2007) 1.36

Use of cancer control referrals by 2-1-1 callers: a randomized trial. Am J Prev Med (2012) 1.35

Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer (2004) 1.34

An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol (2011) 1.32

Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment. Oncologist (2007) 1.32

Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry (2014) 1.30

Patient navigation for breast and colorectal cancer treatment: a randomized trial. Cancer Epidemiol Biomarkers Prev (2012) 1.29

Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer (2005) 1.28

Insight in the prediction of chemotherapy-induced nausea. Support Care Cancer (2009) 1.28

Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood. Environ Mol Mutagen (2004) 1.27

Study protocol: a randomized controlled trial of patient navigation-activation to reduce cancer health disparities. BMC Cancer (2010) 1.26

Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat (2005) 1.24

Perceived discrimination, psychological distress, and current smoking status: results from the Behavioral Risk Factor Surveillance System Reactions to Race module, 2004-2008. Am J Public Health (2012) 1.23

What are successful recruitment and retention strategies for underserved populations? Examining physical activity interventions in primary care and community settings. Transl Behav Med (2011) 1.20

A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer (2010) 1.19

Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer (2011) 1.19

Cancer patients' expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center--Community Clinical Oncology Program study of 938 patients from community practices. Cancer (2004) 1.16

Social and cultural factors are related to perceived colorectal cancer screening benefits and intentions in African Americans. J Behav Med (2009) 1.15

Prevention of pegfilgrastim-induced bone pain: a phase III double-blind placebo-controlled randomized clinical trial of the university of rochester cancer center clinical community oncology program research base. J Clin Oncol (2012) 1.15

Decision-making role preferences of patients receiving adjuvant cancer treatment: a university of Rochester cancer center community clinical oncology program. Support Cancer Ther (2004) 1.14

The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage (2003) 1.13

Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw (2007) 1.13

A Phase II/III Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Ginger (Zingiber officinale) for Nausea Caused by Chemotherapy for Cancer: A Currently Accruing URCC CCOP Cancer Control Study. Support Cancer Ther (2007) 1.13

Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psychooncology (2005) 1.13

Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Support Care Cancer (2013) 1.12

Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. Radiother Oncol (2009) 1.11

Effects of Tai Chi Chuan on insulin and cytokine levels in a randomized controlled pilot study on breast cancer survivors. Clin Breast Cancer (2011) 1.11

A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J Support Oncol (2009) 1.11

Caring for Somali women: implications for clinician-patient communication. Patient Educ Couns (2007) 1.10

Anticipatory nausea and vomiting. Support Care Cancer (2010) 1.09

Patient-reported outcome measures suitable to assessment of patient navigation. Cancer (2011) 1.09

Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support Care Cancer (2011) 1.07

Sublethal radiation injury uncovers a functional transition during erythroid maturation. Exp Hematol (2011) 1.05

Stereotactic body radiotherapy for treatment of adrenal metastases. Int J Radiat Oncol Biol Phys (2009) 1.04

Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program. Clin Trials (2012) 1.03

IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest (2010) 1.02

Interleukin 1beta (IL1B) signaling is a critical component of radiation-induced skin fibrosis. Radiat Res (2006) 1.01

The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol (2003) 1.01

The effect of modafinil on cognitive function in breast cancer survivors. Cancer (2009) 1.00

Exercise for the management of side effects and quality of life among cancer survivors. Curr Sports Med Rep (2009) 0.99

Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study. J Pain Symptom Manage (2008) 0.98

Cancer-related stress and complementary and alternative medicine: a review. Evid Based Complement Alternat Med (2012) 0.98

A systematic review of financial incentives for dietary behavior change. J Acad Nutr Diet (2014) 0.98

Supportive-expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psychooncology (2008) 0.98

Assessing self-efficacy for coping with cancer: development and psychometric analysis of the brief version of the Cancer Behavior Inventory (CBI-B). Psychooncology (2011) 0.98

Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer. Radiat Oncol (2011) 0.98

Past, present, and future of oxygen in cancer research. Adv Exp Med Biol (2005) 0.97

Translating evidence into population health improvement: strategies and barriers. Annu Rev Public Health (2015) 0.97

Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat (2004) 0.97

Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer. J Biol Chem (2013) 0.97

Clinician-patient communication about physical activity in an underserved population. J Am Board Fam Med (2008) 0.97

Healthcare navigation service in 2-1-1 San Diego: guiding individuals to the care they need. Am J Prev Med (2012) 0.95

Effects of a structured weight-bearing exercise program on bone metabolism among breast cancer survivors: a feasibility trial. Clin Breast Cancer (2010) 0.94